Program

Melissa C. Guzy serves as the Founder and Managing Partner at Arbor Ventures. Prior to establishing Arbor Ventures, Melissa held the role of Managing Partner and was a pivotal member of the Investment Committee at VantagePoint Capital Partners. Her current portfolio of board positions encompasses InCountry, Tabby, Ready, Nomi Health, and TrueAccord. Notably, Melissa played the role of investor board member for Paidy, a company that was subsequently acquired by Paypal for an impressive $2.88 billion. Beyond her corporate involvements, Melissa also holds a position on the Board of Trustees at The Jackson Laboratory, an institution committed to uncovering precise genomic solutions for diseases and fostering global collaboration within the biomedical community to enhance human health.

Melissa’s academic journey led her to Wellesley College, and she further advanced her education by obtaining a Master of Science in Finance from the University of Florida. Her scholarly contributions include the paper “Venture Capital Returns and Public Market Performance.” She holds a prominent role as the Co-Chair of the Venture Committee within the Hong Kong Venture Capital and Private Equity Association (HKVCA), and she also serves on the Board of Directors of the HKVCA. Notably, she was previously a member of the Hong Kong SFC on Innovation. Melissa’s expertise extends to academia, where she served as a guest lecturer on Venture Capital Industry at prestigious institutions such as the University of Florida, Hong Kong University, Chinese University of Hong Kong, and the Hong Kong University of Science and Technology.

Furthermore, Melissa is a distinguished Hopkins Fellow and an alumna of the Women’s Leadership Program at Harvard University. Her accomplishments have garnered recognition, including being listed as a Top 100 Influencer in Fintech by NxtBnk, earning the designation of an AlwaysOn Fintech Power Player, and being acknowledged as one of the Top 13 Women in Asia who are Tech Influencers.

Dr. Wu is a committed and proactive professional with a highly successful local and global background in basic science research, clinical development, medical affairs, health economics and commercialization throughout the whole development circle of drugs & devices. Before he founded Arctic Vision, he was the Head of Terns China Biotechnology where he was responsible for directing and overseeing all aspects of R&D activities as well as general management responsibilities. Before Terns, he was the Executive Director at Allergan China where he was responsible for Allergan's overall R&D, clinical, medical and portfolio strategy for China. Previous to his work at Allergan, he was based in Novartis Basel headquarter, Hong Kong, and Taiwan and held various positions with increasing responsibilities and gained in first-hand global experience.

Besides his extensive experience in the healthcare industry, Dr. Wu also owns multiple social titles such as the Senior Fellow of Social Enterprise Research Academy, the Outstanding Young Entrepreneur of Guangdong-HK-Macao Bay Area, and Economic Innovator in the New Era.

Dr. Wu graduated with a bachelor's degree in Biochemistry from the Hong Kong University of Science and Technology (HKUST), where he also obtained his Ph.D. in Biochemistry. He also holds 22 patents and 35 academic publications.

Mr. Andy Wong is the Head of Innovation and Technology at Invest Hong Kong (InvestHK), the government department responsible for attracting and facilitating foreign direct investment into Hong Kong.  His key focused technology segments include biotech, medical devices, healthcare, AI and robotics, microelectronics, new materials, and green technologies.

Mr. Wong has wealth strategy consulting and business development experience in high tech sector. Before joining InvestHK, Mr. Wong held various senior positions at a global leading consulting firm and a global Fortune 500 technology company specialising in corporate strategy and business development.

Mr. Wong graduated from the University of Birmingham, the UK with First Class Honor Degree in Electronic and Electrical Engineering, a Master Degree in Commerce from the University of New South Wales, Australia and a Master of Science in Real Estate from the University of Hong Kong.  Mr. Wong is a Chartered Engineer (CEng) from The Institution of Engineering and Technology, the UK; and is a Member of the Certified Practicing Accounting, (CPA) Australia by training.

Amit has spent 25 years in South Asia as an early pioneer and leader in the development of the region's Venture Capital Industry. Amit was the Vice Chairman of Business Angels Network of SouthEast Asia (BANSEA), which is Asia's oldest and largest angel investment network. He helped scale the network both in terms of its impact and reach where today it has supported the development of over 15000 Founders and made 400 investments in the region.

Amit has since shaped Jungle's investment approach and philosophy over the years, and in turn overseen investments in some of Jungle's leading portfolio companies such as Travelmob (exit to HomeAway), Zipdial (exit to Twitter), TradeGecko (exit to Intuit), Pomelo Fashion, Reddoorz, Kredivo amongst other stars. His involvement in these companies goes beyond investment and he has actively led various efforts ranging from recruiting board members, recruiting and mentoring key executives, to forming strategic partnerships and handcrafting cross border scale up plans.

Previously, Amit held executive positions in sales and business development roles at Progress Software ($1.6 Billion NASDAQ listed software giant), STT Communications backed and Singapore based Elipva (acquired by a Hong Kong Listed Company) and earlier at Tata Infotech Ltd, India (Acquired by TCS for ~$259m). In 2006, Amit switched gears & began his journey as an entrepreneur when he founded Ettamina Studios, a Singapore-India based animation studio with ambitions to build a global company from Asia. A passion which later led him to start Jungle Ventures and more recently invest in disruptive ideas such as Livspace and Builder.AI where he continues to help them grow into global category creators.

He is a Kauffman Fellow, one of the earliest from South East Asia and currently also a member of Singapore Government's Advisory Council on the Ethical Use Of Artificial Intelligence and Data. Amit holds a Bachelor’s degree with a major in Computer Science.

Anson joined KPMG in Hong Kong in 1999 and is currently a Partner based in the Hong Kong office heading up the Consumer & Retail Practice in the Asia Pacific region. Today, he is part of the KPMG Global Consumer & Retail Leadership team.

Anson has been active in driving a number of thought leadership reports and executive briefings for senior executives covering innovation and consumers in China and across the Asia Pacific region. He has worked with many corporates to understand the complex markets we live in and current levels of disruption being seen with various thought leadership reports including Global Mobile Payments, Consumers & Convergence, Mobilizing Innovation: The Changing Landscape of Disruptive Technologies, The Rise of the Digital Multi-tasker, Be a Smarter Start-up, MNCs in China, Made in China 2025, China’s Connected Consumers, Global Connected Consumers, Connecting Hong Kong – Perspectives on our future as a smart city, Connected Cities – insights across the ASPAC region, Retail Recharged, The Future of Seamless Commerce in Asia Pacific and The Changing Face of Commerce series.

Today, he works with a growing number of C-level executives as a trusted advisor in looking at the customer and providing the best in client innovation whilst acting as the Lead Partner for a number of strategic accounts in both the consumer and tech arena across the Asia Pacific region.

He strongly believes in supporting local communities with various outreach programs and nurturing the next generation of young leaders. Anson is a frequent speaker at conferences and events around the globe and has completed his Executive Masters in Innovation & Technology with the Poly University as well as the MIT Executive Leadership & Innovation Program.

Clement has over 20 years of management experience with multinational corporations across diverse industries.

Clement started his career with Jardine Matheson as group management trainee and worked in multiple verticals. A serial entrepreneur, Clement started multiple start-ups and successfully exited through M&As.

Clement leads RIT Biotech, a subsidiary of ZERO Biotech, to become the leading downstream nuclear medicine player in Hong Kong. Clement joined RIT Biotech in 2018 and was appointed as the CEO of ZERO Biotech in 2020.

Clement received a master degree in Mechanical Engineering from Stanford University.